Opinion of Advocate General Wathelet delivered on 25 April 2018.

Core Citations

WORK EXPRESSION OF

• Opinion of Advocate General Wathelet delivered on 25 April 2018.

This document cites

• Employment Rights Act 1996
• Patents Act 1977
• Merck Canada Inc. v Accord Healthcare Ltd and Others.
• Actavis Group PTC EHF and Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. KG.
• Farmitalia Carlo Erba Srl.



See all quotations

• Astrazeneca AB v Comptroller General of Patents, Designs and Trade Marks.
• University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Trade Marks.
• Arne Forsgren v Österreichisches Patentamt.
• Georgetown University and Others v Comptroller General of Patents, Designs and Trade Marks.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Yeda Research and Development Company Ltd and Aventis Holdings Inc. v Comptroller General of Patents, Designs and Trade Marks.
• Seattle Genetics Inc. v Österreichisches Patentamt.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.
• Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.
• Eli Lilly and Company Ltd v Human Genome Sciences Inc.
• Farmitalia Carlo Erba Srl.
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products